GlassScriptPhysician profile
Barbara Grubbs
NPI 1497903801
$3,454.26
in general payments reported to CMS, 2019-2025
20 companies · $700 in 2025
The $700 reported for 2025 was more than what 82% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $552 · 2022: $1,109 · 2023: $968 · 2024: $125 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,793.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $613.62 | 2022-2025 | |
| Abbott Laboratories | $339.66 | 2022-2023 | Freestyle Libre 3 |
| Abbvie INC. | $323.67 | 2022-2023 | |
| Insmed, INC. | $229.18 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $212.81 | 2022-2023 | |
| Boston Scientific Corporation | $201.04 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $175.31 | 2021-2022 | |
| Argenx US, INC. | $131.71 | 2023 | Vyvgart |
| Jazz Pharmaceuticals INC. | $129.31 | 2022 | |
| Astellas Pharma US INC | $128.93 | 2025 | Veozah |
| Idorsia Pharmaceuticals US INC | $124.86 | 2024 | Quviviq |
| Advanced Oxygen Therapy INC. | $122.63 | 2023 | Topical Oxygen Chamber For Extremities |
| Gilead Sciences, INC. | $121.74 | 2025 | Descovy |
| Kowa Pharmaceuticals America, INC. | $119.86 | 2025 | Zoryve |
| Teva Pharmaceuticals USA, INC. | $101.11 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $99.77 | 2021 | |
| Cvrx, INC. | $88.10 | 2022 | |
| Exact Sciences Corporation | $82.94 | 2025 | The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $75.70 | 2022 | |
| Guerbet LLC | $32.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Grubbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.